Helmut Rasch

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [⁹⁰Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

Anna Imhof, Philippe Brunner, Nicolas Marincek et al. · Journal of Clinical Oncology · 2011 · 616 citations

A randomised, controlled trial of bosentan in severe COPD

Daiana Stolz, Helmut Rasch, A. Linka et al. · European Respiratory Journal · 2008 · 364 citations · Full text

Endothelin-receptor Antagonist Bosentan, Hypertension, Advanced Lung Disease +18

Knee-to-Ankle Mosaicplasty for the Treatment of Osteochondral Lesions of the Ankle Joint

Víctor Valderrábano, André Leumann, Helmut Rasch et al. · The American Journal of Sports Medicine · 2009 · 253 citations

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis

Martin Fuchs, Matthias Briel, Thomas Daikeler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 193 citations · Full text

Vascular Disease, Vasculitis, Cardiovascular Disease +5

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5

Damian Wild, Helmut R. Mäcke, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2004 · 186 citations

Positron Emission Tomography, Engineering, Health Sciences +10